Review

PD-1, PD-L1 mechanism and cancer treatment

Aslı Babayakalı, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.019
743 1090

Neurotransmitters and hair loss

Aylin Kayaaltı, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.020
821 6897

RIPK1 and obesity-induced inflammation

Aslı Melike Ekmekçi, Fehmi Balandi, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.021
751 942

Terazosin and neuroprotection

Ayşe Yürekli, Atakan Ölçenoğlu, Manolya Yıldız, Begüm Arda, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.022
902 1282

Tumor markers and clinical use

Burak Akverdi, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.023
919 1541

Alkaliptosis: A new strategy for cancer therapy

Beyza Emine Kılınç, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.024
942 1273

Subgenual anterior cingulate cortex and psychiatric disorders

Berfin Sıla Akdoğdu, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.025
754 896

Bone marrow transplantation use on treatment solid tumors

İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.026
742 1136

Effect of mitochondrial dysfunction and oxidative stress on the pathogenesis of autism spectrum disorders

Umut Yücel, İrem Kahramanoğlu, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.028
1174 1094

Cancer cells and alpha-ketoglutarate

Yalda Sadeghian, İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.029
785 1811